Blocking the PI3K/PKB Pathway in Tumor Cells
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
449-462
Author(s):
F. Stauffer, P. Holzer and C. Garcia-Echeverria
Transcriptionally Targeted Adenovirus Vectors
Journal:
Current Gene Therapy
Volume:
5
Page:
411-427
Author(s):
Hamid Sadeghi and Mary M. Hitt
Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches
Journal:
Current Medicinal Chemistry
Volume:
12
Page:
2075-2094
Author(s):
Mathea Sophia Galanski*, Michael A. Jakupec and Bernhard K. Keppler
DNA Drug Design for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2811-2823
Author(s):
Y. S. Cho-Chung
Oligonucleotides as Anticancer Agents: From the Benchside to the Clinic and Beyond
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2825-2840
Author(s):
F. M. Coppelli and J. R. Grandis
Insulin Secretagogues, Sulfonylurea Receptors and KATP Channels
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2699-2716
Author(s):
J. Bryan, A. Crane, W. H. Vila-Carriles, A. P. Babenko and L. Aguilar-Bryan
Inflammation and Cancer: When NF-κB Amalgamates the Perilous Partnership
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
325-344
Author(s):
Marina A. Dobrovolskaia and Serguei V. Kozlov
Molecular Targets from VHL Studies into the Oxygen-Sensing Pathway
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
345-356
Author(s):
M. A. Maynard and M. Ohh
Retinoids as Therapeutic Agents: Today and Tomorrow
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
5
Page:
755-760
Author(s):
Valerie Vivat-Hannah and F. Christopher Zusi
Endothelial Progenitor Cells as Potential Drug Targets
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
5
Page:
277-286
Author(s):
T. Thum and J. Bauersachs